BNP Paribas Financial Markets’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.6K Buy
2,354
+867
+58% +$9.54K ﹤0.01% 4994
2025
Q4
$11.9K Buy
1,487
+173
+13% +$4.04K ﹤0.01% 5126
2025
Q3
$62.9K Buy
1,314
+661
+101% +$14.7K ﹤0.01% 4497
2025
Q2
$8.16K Buy
653
+280
+75% +$4.03K ﹤0.01% 4893
2025
Q1
$6.49K Sell
373
-6,615
-95% -$196K ﹤0.01% 4804
2024
Q4
$266K Buy
6,988
+2,079
+42% +$107K ﹤0.01% 3701
2024
Q3
$164K Buy
4,909
+4,470
+1,018% +$188K ﹤0.01% 3331
2024
Q2
$14.9K Buy
+439
New +$24.3K ﹤0.01% 3680

Other funds holding KRRO

BNP Paribas Financial Markets's KRRO Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Korro Bio (KRRO) stake by 58% in Q1 2026, buying an estimated $9.54K and bringing the position to 2,354 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4994.

BNP Paribas Financial Markets first reported a position in KRRO in Q2 2024 and has held it in 8 quarters since. The position peaked at $266K in Q4 2024. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • BNP Paribas Financial Markets held 2,354 shares of Korro Bio worth $26.6K as of Q1 2026.
  • BNP Paribas Financial Markets bought 867 Korro Bio shares in Q1 2026, an estimated $9.54K.
  • Korro Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4994 holding.
  • BNP Paribas Financial Markets first reported a position in Korro Bio in Q2 2024 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Korro Bio position peaked at $266K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.